Monocyte Count as a Prognostic Biomarker in Patients with Idiopathic Pulmonary FibrosisMichael Kreuter, Toby M. Maher, Joyce Lee et al.|American Journal of Respiratory and Critical Care Medicine|2021Cited by 198
Validation of a 52-gene risk profile for outcome prediction in patients with idiopathic pulmonary fibrosis: an international, multicentre, cohort studyJose D. Herazo‐Maya, Naftali Kaminski, Brenda Juan-Guardela et al.|The Lancet Respiratory Medicine|2017Cited by 191
Transcriptional regulatory model of fibrosis progression in the human lungJohn E. McDonough, Naftali Kaminski, Farida Ahangari et al.|JCI Insight|2019Cited by 184
Extracellular Mitochondrial DNA Is Generated by Fibroblasts and Predicts Death in Idiopathic Pulmonary FibrosisChangwan Ryu, Glenda Trujillo, Huanxing Sun et al.|American Journal of Respiratory and Critical Care Medicine|2017Cited by 172
SH2 Domain–Containing Phosphatase-2 Is a Novel Antifibrotic Regulator in Pulmonary FibrosisArgyrios Tzouvelekis, Naftali Kaminski, Guoying Yu et al.|American Journal of Respiratory and Critical Care Medicine|2016Cited by 52